Over 25% of Macquarie investors vote against structure that has rewarded executives with pay rivalling Wall Street CEOsRead More
You might also be interested in reading Reviva Pharmaceuticals GAAP EPS of -$0.13.
Over 25% of Macquarie investors vote against structure that has rewarded executives with pay rivalling Wall Street CEOsRead More
You might also be interested in reading Reviva Pharmaceuticals GAAP EPS of -$0.13.